Evidence map›Paper›PMID 28456934›Full record

ArticleMolecular neurobiology2018

Lhx9 Is Required for the Development of Retinal Nitric Oxide-Synthesizing Amacrine Cell Subtype.

Revathi Balasubramanian, Andrew Bui, Xuhui Dong, Lin Gan

Abstract read
In one paragraph

Article in Molecular neurobiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Biology open · 2021
    Article
  8. Article
  9. A human cell atlas of fetal gene expression.Science (New York, N.Y.) · 2020
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Revathi BalasubramanianDepartment of Ophthalmology and Flaum Eye Institute, University of Rochester, Rochester, NY, 14642, USA.
Andrew BuiDepartment of Ophthalmology and Flaum Eye Institute, University of Rochester, Rochester, NY, 14642, USA.
Xuhui DongInstitute of Life Sciences, Hangzhou Normal University, Hangzhou, Zhejiang, 310036, China.
Lin GanDepartment of Ophthalmology and Flaum Eye Institute, University of Rochester, Rochester, NY, 14642, USA. lin_gan@urmc.rochester.edu.
University of Rochester · USHangzhou Normal University · CN

Funding

The Roles of LIM-Homeodomain Transcription Factors in Retinal DevelopmentR01EY026614 · NEI · UNIVERSITY OF ROCHESTER · PI GAN, LIN · 2016 to 2020
$1.9M
National Eye Institute EY026614NEI NIH HHS R01 EY026614Zhejiang Province Science Grant 2012C13023-1
6 · The paper itself

Abstract

Amacrine cells are the most diverse group of retinal neurons. Various subtypes of amacrine interneurons mediate a vast majority of image forming and non-image forming visual functions. The transcriptional regulation governing the development of individual amacrine cell subtypes is not well understood. One such amacrine cell subtype comprises neuronal nitric oxide synthase (nNOS/bNOS/NOS1)-expressing amacrine cells (NOACs) that regulate the release of nitric oxide (NO), a neurotransmitter with physiological and clinical implications in the retina. We have identified the LIM-homeodomain transcription factor LHX9 to be necessary for the genesis of NOACs. During retinal development, NOACs express Lhx9, and Lhx9-null retinas lack NOACs. Lhx9-null retinas also display aberrations in dendritic stratification at the inner plexiform layer. Our cell lineage-tracing studies show that Lhx9-expressing cells give rise to both the GAD65 and GAD67 expressing sub-populations of GABAergic amacrine cells. As development proceeds, Lhx9 is downregulated in the GAD65 sub-population of GABAergic cells and is largely restricted to the GAD67 sub-population of amacrine cells that NOACs are a part of. Taken together, we have uncovered Lhx9 as a new molecular marker that defines a subset of amacrine cells and show that it is necessary for the development of the NOAC subtype of amacrine cells.

Indexed as

Amacrine CellsAnimalsCell LineageDendritesGABAergic NeuronsGlutamate DecarboxylaseLIM-Homeodomain ProteinsMiceNitric OxideNitric Oxide Synthase Type IPhenotypeRetinaRetinal NeuronsTranscription FactorsGlutamate Decarboxylaseglutamate decarboxylase 1glutamate decarboxylase 2Lhx9 protein, mouseLIM-Homeodomain ProteinsNitric OxideNitric Oxide Synthase Type ITranscription FactorsAmacrine cell subtypeLIM-homeodomain transcription factorRetinaRetinal lamination

Identifiers

PMID28456934
PMCPMC5898628
OpenAlexW2608772837

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.